Ajanta Pharma Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	10,560	9,204	8,162	5,880	7,127
Depreciation & Amortization	1,731	1,359	1,304	1,267	1,214
Other Amortization	-	82.2	50.1	41	39.4
Loss (Gain) From Sale of Assets	18.7	6	-34.9	61.9	38.7
Loss (Gain) From Sale of Investments	-80.4	-113.1	-20.1	14.8	-52.3
Stock-Based Compensation	15.3	38.8	54.9	2.2	3
Other Operating Activities	-423.8	-793.7	-667.1	-14.1	-748.2
Change in Accounts Receivable	-5,908	804.8	-1,789	-105.5	-2,697
Change in Inventory	-309.5	-745.1	-123	-223.7	-256.6
Change in Accounts Payable	907.9	-84.5	408.5	969.1	-480.2
Change in Other Net Operating Assets	-1,219	1,814	505.5	28.6	1,430
Operating Cash Flow	5,292	11,572	7,851	7,921	5,617
Operating Cash Flow Growth	-54.27%	47.41%	-0.89%	41.02%	-2.53%
Capital Expenditures	-3,652	-3,179	-1,524	-1,745	-1,488
Sale of Property, Plant & Equipment	54.1	11.4	133.8	7.3	183.8
Investment in Securities	-1,142	-1,040	1,776	-3,907	287.8
Other Investing Activities	449.8	442.4	267.9	48.7	275.8
Investing Cash Flow	-4,289	-3,765	653.9	-5,596	-741
Long-Term Debt Issued	2,094	11	0.6	-	2.3
Total Debt Issued	2,094	11	0.6	-	2.3
Long-Term Debt Repaid	-	-114.6	-125.5	-112.3	-137.5
Net Debt Issued (Repaid)	2,094	-103.6	-124.9	-112.3	-135.2
Issuance of Common Stock	-	0.1	-	-	-
Repurchase of Common Stock	-	-3,513	-3,883	-	-2,856
Common Dividends Paid	-3,497	-3,494	-6,422	-896.9	-822.1
Other Financing Activities	-276	-223.5	-81.3	-72.8	-783.9
Financing Cash Flow	-1,679	-7,334	-10,511	-1,082	-4,597
Net Cash Flow	-676.5	473	-2,006	1,243	279
Free Cash Flow	1,640	8,393	6,327	6,176	4,129
Free Cash Flow Growth	-80.46%	32.66%	2.44%	49.59%	2.02%
Free Cash Flow Margin	2.92%	18.06%	15.03%	16.50%	12.36%
Free Cash Flow Per Share	13.13	67.05	50.21	48.20	31.84
Cash Interest Paid	-	207.4	72.1	58.4	102
Cash Income Tax Paid	-	3,230	3,121	1,513	2,391
Levered Free Cash Flow	424.81	6,621	1,165	8,146	1,893
Unlevered Free Cash Flow	525.5	6,750	1,210	8,183	1,956
Change in Working Capital	-6,529	1,789	-997.8	668.5	-2,004

Source: S&P Global Market Intelligence. Standard template. Financial Sources.